NEW YORK (GenomeWeb News) – Mizuho Securities today downgraded Fluidigm to Neutral, citing a cooling sentiment to both the genomics and academic markets.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.